Selected Current Organizations: - Independent Physician Solutions - AllCare Complete - Strategic Veterinary Partners - New World Angels

Key Accomplishments:• Built and led a highly successful M&A team that created extraordinary value appreciation and return on investment for our private equity owners• Entered five new business lines, 16 new states, and added hundreds of new hospital clients via acquisitions• Aspirion acquisitions were selectively chosen and efficiently integrated, collectively averaging double-digit growth and several points of EBITDA margin expansion post-closeRole and Responsibilities: • Built and led a full-service Corporate Development team (sourcing, execution and integration) and developed the acquisition strategy in collaboration with our owners and the Board, resulting in exceptional growth, EBITDA margin expansion and new market entry over the four years from Aquiline Capital’s initial investment through the successful sale to Linden Capital in 2022. • Developed and managed a high-touch acquisition sourcing program that continuously fed a deep pipeline of transaction candidates, ultimately resulting in 80% of Aspirion’s acquisitions originating outside of advisor-led auctions / competitive processes• Created the process and protocols that allowed Aspirion to efficiently execute acquisitions in as few as 40 days from LOI to close while minimizing business disruption to the targets• Fully integrated acquisitions and recognized projected synergies within 60 days post-close by developing detailed integration plans weeks before the transaction close date, utilizing and innovating process tools to meet integration milestones, and implementing highly-orchestrated communication campaigns with the target’s clients and employees

Brought on board to build and lead the business development team and establish the platform to drive the company’s national growth initiatives. Assumed leadership for the Florida market, developing strategic plans, processes, and relationships to actualize the vision of corporate leadership. Promoted to Vice President and co-led the national business development strategy, managing a team of 16 nationwide and executing a targeted mergers and acquisition strategy for this Medicare Advantage and population health focused, $11B, Fortune 200 company, caring for approximately 2M patients in 7 states. • Conducted extensive research to identify healthcare providers suitable for acquisition, and built relationships to understand their business models and ensure the continued delivery of exceptional patient care.• Led teams of professionals conducting due diligence, creatively structured acquisition deals, and drove complex negotiations with physicians and advance care practitioners (ACPs) to achieve win-win outcomes. • Developed systems to standardize the transaction process, including acquisition/financial models to accurately value the businesses, and introduced processes to streamline internal and external communications and company-wide deal reviews and approvals.

Partnered with corporate executives to execute transformational transactions, develop long-term financial models, optimize capital structures, and create strategic plans that supported client operational goals. Led numerous cross-functional transaction teams of 2-8 junior bankers from M&A, equity and debt coverage, and financial sponsor groups. • Drafted public filings, including S-1s and prospectus supplement documents as well as private financing and M&A materials, including management presentations, confidential information memoranda, and financial models. Key Accomplishments> Led the execution of 45 transactions, totaling approximately $7.5B in total M&A transaction value and $6.0B in total book run financings> Selected by senior leadership to organize and lead the inaugural Jefferies Global Healthcare Conference in New York, one of the largest healthcare investment banking conferences in the world with 3,000+ participants and 300+ presenting companies.

• Developed pitchbook for successful bake-off of one of the largest healthcare services IPOs in 2009, including positioning and preliminary valuation• Evaluated target in $6 billion buy-side M&A transaction through detailed profiling, pipeline valuation, comparable company analysis, and sales projections

Experience includes roles with a Gubernatorial campaign, the Florida Insurance Commissioner, the Office of the Governor of Florida, and the State of Florida Commission on Ethics.